Related Experiment Video
Updated: May 17, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Factor XIII Deficiency and Measurement
Catherine Pauline M Hayward1, Natalie Mathews2
1Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Special Coagulation, Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, Canada.
Abstract:
Factor XIII (FXIII) is a thrombin-activated coagulation factor that stabilizes the fibrin clot via covalent cross-linking of fibrin. Inherited and acquired FXIII deficiencies are important causes of bleeding, with acquired deficiencies being about 10 fold more prevalent. Acquired FXIII deficiency can arise in the setting of consumptive coagulopathies; massive blood loss; severe infections; hepatic dysfunction; acquired inhibitors of FXIII; and deficiencies of uncertain significance. FXIII deficiency is not detected by routine coagulation assays and requires evaluation by quantitative FXIII activity and antigen assays. Bethesda assay modifications of FXIII activity assays are helpful to diagnose acquired FXIII inhibitors.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins

